Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company advancing numerous gene therapies that could cure rare childhood diseases. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for seeking gene therapy cures for devastating diseases and making a difference for patients. Become an integral part of a small, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. In addition to a competitive compensation package featuring a generous 401K match and stock options, positions include excellent health benefits.
For more information, please visit www.rocketpharma.com.
Twitter: https://bit.ly/2O28aHx
YouTube: https://bit.ly/3iNSXIu
Location: United States, New Jersey, Cranbury
Employees: 51-200
Phone: +1 646-440-9100
Founded date: 2015
Investors 4
| Date | Name | Website |
| 11.01.2022 | Civilizati... | civilizati... |
| - | Frazier Li... | frazierls.... |
| - | Sahsen Ven... | sahsen.com |
| - | LifeSci Ve... | lifesciven... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 13.12.2021 | Rocket Pharmaceuticals Presents Positive Clinical Data from ... | Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and su... | marketscre... |
| 22.03.2021 | Rocket Pharmaceuticals Announces Updated Positive Preliminar... | CRANBURY, N.J.--(BUSINESS WIRE)--Mar 22, 2021-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clini... | oaoa.com/n... |
| 09.03.2021 | Rocket Pharmaceuticals Receives FDA Regenerative Medicine Ad... | CRANBURY, N.J.--(BUSINESS WIRE)--Mar 9, 2021-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinic... | oaoa.com/n... |
| - | Rocket Pharmaceuticals Reports Fourth Quarter and Full Year ... | CRANBURY, N.J.--(BUSINESS WIRE)--Feb 25, 2021-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clini... | oaoa.com/n... |